ANCEF PRESCRIBING INFORMATION PDF

Ancef official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more. HIGHLIGHTS OF PRESCRIBING INFORMATION. These highlights do not include all the information needed to use CEFAZOLIN injection safely and effectively. When culture and susceptibility information are available, they Prescribing Cefazolin for injection in the absence of a proven or strongly suspected bacterial .

Author: Grojas Zulkitaur
Country: Sao Tome and Principe
Language: English (Spanish)
Genre: History
Published (Last): 1 April 2017
Pages: 332
PDF File Size: 10.63 Mb
ePub File Size: 4.6 Mb
ISBN: 691-8-53513-703-5
Downloads: 98695
Price: Free* [*Free Regsitration Required]
Uploader: Mekinos

Clorindione The risk or severity of bleeding can be increased when Informatio is combined with Clorindione. Phosphocreatine Cefazolin may decrease the excretion rate of Phosphocreatine which could result in a higher serum level.

Cangrelor The therapeutic efficacy of Cangrelor can be decreased when used in combination with Cefazolin. Enasidenib The excretion of Cefazolin can be decreased when combined with Enasidenib.

Losartan The excretion of Cefazolin can be decreased when combined with Losartan. Cefadroxil Cefazolin may decrease the excretion rate of Cefadroxil which could result in a higher serum level.

Urokinase The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefazolin.

Capecitabine Cefazolin may decrease the excretion rate of Capecitabine which could result in a higher serum level. Pidotimod Cefazolin may decrease the presribing rate of Pidotimod which could result in a higher serum level.

Microorganism Zone Diameter mm E. Lamivudine Cefazolin may decrease the excretion rate of Lamivudine which could result in a higher serum level. Cimetidine Cefazolin may decrease the excretion rate of Cimetidine which could result in a higher serum level.

Neonates younger than 32 weeks gestation and 14 days and older. Flunoxaprofen The risk or severity of nephrotoxicity can be increased when Cefazolin is combined with Flunoxaprofen.

Sisomicin The risk or severity of nephrotoxicity can be increased when Cefazolin is combined with Sisomicin. Recipient’s Email Separate multiple email address with a comma Please enter valid email address Recipient’s email is required. Perscribing Cefazolin may decrease the excretion rate of Imidafenacin which could result in a higher serum level.

Etafedrine Cefazolin may decrease the excretion rate of Etafedrine which could result in a higher serum level. Tropisetron Cefazolin may decrease the excretion rate of Tropisetron which could result in a zncef serum level. Amphotericin B The risk or severity of nephrotoxicity can be increased when Amphotericin B is combined with Cefazolin.

  BICARA HATI DAMYA HANNA PDF

Chloroquine Cefazolin may decrease the excretion rate of Chloroquine which could result in a higher serum level. Edrophonium Cefazolin may decrease the excretion rate of Edrophonium which could result in a higher serum level. Sodium Citrate The therapeutic efficacy of Sodium Citrate can be decreased when used in combination with Cefazolin. Iloprost The therapeutic efficacy of Iloprost can be decreased when used in combination with Cefazolin.

Cisplatin Cefazolin may orescribing the excretion rate of Cisplatin which could result in a higher serum level. GC Hanford Manufacturing Co.

PDR Search

Ethyl biscoumacetate The risk or severity of bleeding can be increased when Cefazolin is combined with Ethyl biscoumacetate. Tenecteplase The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefazolin.

Pramipexole Cefazolin may decrease the excretion rate of Pramipexole which could result in a higher serum level. Cefazolin has not been studied for use during labor and delivery. Trimetrexate Cefazolin may decrease the excretion rate of Trimetrexate which could result in a higher serum level. Potassium sulfate Cefazolin may decrease the excretion rate of Potassium sulfate which could result in a higher serum level. Tolfenamic Acid The risk or severity of nephrotoxicity can be increased when Cefazolin is combined with Tolfenamic Acid.

Ipilimumab Cefazolin may decrease the excretion rate of Ipilimumab which could result in a higher serum level. Hydroxocobalamin Cefazolin may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level. Delafloxacin Cefazolin may decrease the excretion rate of Delafloxacin which could result in a higher serum level. Procainamide Cefazolin may decrease the excretion rate of Procainamide which could result in a higher serum level.

Iobenguane sulfate I Cefazolin may decrease the excretion rate of Iobenguane sulfate I which could result in a higher serum level. Edetate disodium anhydrous The therapeutic efficacy of Edetate disodium anhydrous can be decreased when used in combination with Cefazolin. Diatrizoate Cefazolin may decrease the excretion rate of Diatrizoate which could result in a higher serum level. Dalfampridine Cefazolin may decrease the excretion rate of Dalfampridine which could result in a higher serum level.

  ITU-R BT.601-5 PDF

Ceftizoxime The risk or severity of nephrotoxicity can be increased when Cefazolin is combined with Ceftizoxime. Neonates younger than 32 weeks gestation and 0 to 13 days.

Ancef – FDA prescribing information, side effects and uses

Epoprostenol Cefazolin may decrease the excretion rate of Epoprostenol which could result in a higher serum level. Acemetacin The risk or severity of nephrotoxicity can be increased when Cefazolin is combined with Acemetacin.

Dinoprostone The excretion of Cefazolin can be decreased when combined with Dinoprostone. The prophylactic administration of Ancef preoperatively, intraoperatively, and postoperatively may reduce the incidence of certain postoperative infections in patients undergoing surgical procedures which are classified as contaminated or potentially contaminated e.

Estradiol acetate Cefazolin may decrease the excretion rate of Estradiol acetate which could result in a higher serum level. Olsalazine The risk or severity of nephrotoxicity can be increased when Olsalazine is combined with Cefazolin. Pentosan Polysulfate The therapeutic efficacy of Pentosan Polysulfate can be decreased when used in combination with Cefazolin.

Streptokinase The therapeutic efficacy of Streptokinase can be decreased when used in combination with Cefazolin. Levomilnacipran Cefazolin may decrease the excretion rate of Levomilnacipran which could result in a infoemation serum level. Tazobactam The excretion of Tazobactam can be decreased when combined with Cefazolin. Bacillus calmette-guerin substrain danish live antigen The therapeutic efficacy of Bacillus calmette-guerin substrain danish live infformation can be decreased when used in combination with Cefazolin.

Melatonin The excretion of Cefazolin can be decreased when combined with Melatonin. Cefozopran The risk or severity of nephrotoxicity can be increased when Cefazolin is combined with Cefozopran. Famotidine The excretion of Cefazolin can be decreased when combined with Famotidine.